A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
出版年份 2012 全文链接
标题
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
作者
关键词
-
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 23, Issue 9, Pages 2257-2276
出版商
Springer Nature
发表日期
2012-03-21
DOI
10.1007/s00198-012-1958-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A comparison of case-finding strategies in the UK for the management of hip fractures
- (2012) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2011) Adolfo Díez-Pérez et al. BONE
- Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features
- (2011) Andrea Giusti et al. BONE
- FRAX® with and without Bone Mineral Density
- (2011) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
- (2011) Laura Y. Park-Wyllie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture
- (2011) Edward S. Leib et al. JOURNAL OF CLINICAL DENSITOMETRY
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidance for the adjustment of FRAX according to the dose of glucocorticoids
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk assessment without bone density measurement in routine clinical practice
- (2011) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis: burden, health care provision and opportunities in the EU
- (2011) O. Ström et al. Archives of Osteoporosis
- Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
- (2010) Inès Losada et al. AUTOIMMUNITY REVIEWS
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid
- (2010) Takao Sugiyama et al. Gender Medicine
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007
- (2010) Zhong Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
- (2010) A. Catharine Ross et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of glucocorticoid-induced osteoporosis
- (2010) Juliet Compston Nature Reviews Rheumatology
- Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
- (2010) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
- (2010) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis
- (2009) Raz Yirmiya et al. BIOLOGICAL PSYCHIATRY
- Which Women Should Be Selected for Vertebral Fracture Assessment? Comparing Different Methods of Targeting VFA
- (2009) Edward T. Middleton et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series
- (2009) Reina Armamento-Villareal et al. CALCIFIED TISSUE INTERNATIONAL
- Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells
- (2009) Wendy Mak et al. CALCIFIED TISSUE INTERNATIONAL
- Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates
- (2009) Kuntheavy Ing-Lorenzini et al. DRUG SAFETY
- Timing of Repeat BMD Measurements: Development of an Absolute Risk-Based Prognostic Model
- (2009) Steven A Frost et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for Osteoporosis
- (2009) Nelson B Watts et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular Diseases
- (2009) Ichiro Tatsuno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate-Related Osteonecrosis of the Jaws: A Single-Center Study of 101 Patients
- (2009) Towy Sorel Lazarovici et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
- (2009) S. A. STOCH et al. JOURNAL OF RHEUMATOLOGY
- Bisphosphonate Associated Osteonecrosis of the Jaw
- (2009) A. A. KHAN et al. JOURNAL OF RHEUMATOLOGY
- Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center
- (2009) Adi Cohen et al. JOURNAL OF WOMENS HEALTH
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
- (2009) J. Compston et al. MATURITAS
- Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
- (2009) Lorenz C. Hofbauer et al. MOLECULAR ENDOCRINOLOGY
- FRAX® assessment of osteoporotic fracture probability in Switzerland
- (2009) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
- (2009) H. Kaji et al. OSTEOPOROSIS INTERNATIONAL
- The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
- (2009) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
- (2009) T. Beukelman et al. OSTEOPOROSIS INTERNATIONAL
- Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?
- (2009) M. H. Edwards et al. OSTEOPOROSIS INTERNATIONAL
- Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
- (2009) B. L. Langdahl et al. OSTEOPOROSIS INTERNATIONAL
- BMD, clinical risk factors and their combination for hip fracture prevention
- (2009) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral
- (2009) J. González Macías et al. REVISTA CLINICA ESPANOLA
- Pregnancy outcome following in utero exposure to bisphosphonates
- (2008) Shirley Levy et al. BONE
- Glucocorticoid Excess Affects Cortical Bone Geometry in Premenopausal, but not Postmenopausal, Women
- (2008) Hiroshi Kaji et al. CALCIFIED TISSUE INTERNATIONAL
- Role of Gap Junction, Hemichannels, and Connexin 43 in Mineralizing in Response to Intermittent and Continuous Application of Parathyroid Hormone
- (2008) Priscilla P. Cherian et al. CELL COMMUNICATION AND ADHESION
- Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
- (2008) Feng-Sheng Wang et al. ENDOCRINOLOGY
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
- (2008) Ernest Beng Kee Kwek et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
- (2008) Lilian I Plotkin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Severely Suppressed Bone Turnover and Atypical Skeletal Fragility
- (2008) Maja Visekruna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Revised Clinician’s Guide to the Prevention and Treatment of Osteoporosis
- (2008) Bess Dawson-Hughes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alendronate Protects Premenopausal Women from Bone Loss and Fracture Associated with High-dose Glucocorticoid Therapy
- (2008) Yosuke Okada et al. JOURNAL OF RHEUMATOLOGY
- A Comparison of Calcium, Calcitriol, and Alendronate in Corticosteroid-Treated Premenopausal Patients with Systemic Lupus Erythematosus
- (2008) Swan S. Yeap et al. JOURNAL OF RHEUMATOLOGY
- Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
- (2008) S. Fujiwara et al. OSTEOPOROSIS INTERNATIONAL
- Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
- (2008) J. Compston et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- (2008) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- The incidence and risk of hip fracture in Poland
- (2008) E. Czerwinski et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The cost-effectiveness of alendronate in the management of osteoporosis
- (2007) John A. Kanis et al. BONE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started